Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
3.160
-0.100 (-3.07%)
May 13, 2025, 12:47 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Next-generation Cell and Gene Therapies
2.56M
Log In
Log In
Next-generation Cell and Gene Therapies Growth
-40.25%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
2.56M
Log In
Log In
United States Growth
-40.25%
Log In
Log In